Defining the pathology of a sub-type of schizophrenia

Grant number: 566967 | Funding period: 2009 - 2011



Schizophrenia is a group of disorders with similar symptoms and no way of distinguishing the different disorders. In our brain collection 25% of the subjects with schizophrenia have a particular chemical deficit. Screening gene expression in people with schizophrenia, with and without this deficit will give a global picture of chemical differences between the groups. Understanding the differences between sub-groups of people with schizophrenia will aid the development of better drugs for them.

Related publications (13)

University of Melbourne Researchers